WELLS FARGO & COMPANY/MN - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$11,784,976
-1.2%
761,796
+0.4%
0.00%0.0%
Q2 2023$11,924,662
-19.1%
759,050
-15.1%
0.00%
-25.0%
Q1 2023$14,740,699
+1.6%
894,459
-3.8%
0.00%0.0%
Q4 2022$14,511,464
+26.7%
930,222
+5.3%
0.00%0.0%
Q3 2022$11,453,000
-6.7%
883,090
+1.0%
0.00%0.0%
Q2 2022$12,274,000
+4.6%
874,199
+6.6%
0.00%
+33.3%
Q1 2022$11,738,000
-51.5%
819,733
-53.9%
0.00%
-50.0%
Q4 2021$24,214,000
-33.6%
1,776,538
-20.2%
0.01%
-25.0%
Q3 2021$36,447,000
-4.5%
2,225,055
-1.9%
0.01%0.0%
Q2 2021$38,182,000
-18.2%
2,268,657
-11.3%
0.01%
-20.0%
Q1 2021$46,678,000
+6.3%
2,556,271
+6.0%
0.01%
-9.1%
Q4 2020$43,911,000
+55.9%
2,412,695
+52.8%
0.01%
+37.5%
Q3 2020$28,163,000
+26.1%
1,578,708
+26.8%
0.01%
+33.3%
Q2 2020$22,330,000
+321.6%
1,245,410
+256.9%
0.01%
+200.0%
Q1 2020$5,296,000
-0.2%
348,921
+29.7%
0.00%
+100.0%
Q4 2019$5,309,000
+10.0%
269,124
-4.1%
0.00%0.0%
Q3 2019$4,828,000
+50.3%
280,683
+54.6%
0.00%0.0%
Q2 2019$3,213,000
+96.0%
181,584
+125.7%
0.00%
Q1 2019$1,639,000
+758.1%
80,444
+607.6%
0.00%
Q4 2018$191,00011,3680.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders